Close Menu

NEW YORK (GenomeWeb) – Bio-Rad Laboratories said today that its board of directors has authorized a new share repurchase program, granting the company authority to repurchase up to $250 million of outstanding shares of its stock on a discretionary basis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.